Voloridge Investment Management, LLC Relmada Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.48 - $3.79 $151,208 - $231,080	-60,971 Reduced 40.05%	91,264 $273,000
Q2 2023 Aug 14, 2023	SELL	$2.22 - $3.54 $234,627 - $374,135	-105,688 Reduced 40.98%	152,235 $374,000
Q1 2023 May 15, 2023	SELL	$2.24 - $4.76 $168,389 - $357,828	-75,174 Reduced 22.57%	257,923 $582,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $496,552 - $8.2 Million	228,826 Added 219.45%	333,097 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $1.91 Million - $3.86 Million	104,271 New	104,271 $3.86 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.